Electra Therapeutics, Inc. (ETRA) has 4 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 21, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 21, 2026 | Stagliano Nancy Director | $0 | 511,270 | — | No | |
|
|
||||||
| Sept. 21, 2026 | Koe Gary S. Chief Technical Officer | $0 | 127,312 | — | No | |
|
|
||||||
| Sept. 21, 2026 | Parry Graham Chief Scientific Officer | $0 | 171,008 | — | No | |
|
|
||||||
| Sept. 21, 2026 | Dong Quehuong (Kathy) President & CEO | $0 | 910,968 | — | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free